DBL-583
![]() | |
| Identifiers | |
|---|---|
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C38H50F2N2O3 |
| Molar mass | 620.826 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
DBL-583 is a selective dopamine reuptake inhibitor of the piperazine chemical class.[1] It is the decanoate ester of a hydroxy vanoxerine.[1] DBL-583 breaks down very slowly in the body, lasting for up to a month after a single injection.[1]
See also
References
- ^ a b c Baumann MH, Phillips JM, Ayestas MA, Ali SF, Rice KC, Rothman RB (June 2002). "Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence". Annals of the New York Academy of Sciences. 965 (1): 92–108. Bibcode:2002NYASA.965...92B. doi:10.1111/j.1749-6632.2002.tb04154.x. PMID 12105088. S2CID 27275723.
| Phenylpiperazines |
|
|---|---|
| Benzylpiperazines | |
| Naphthylpiperazines | |
| Quinolinylpiperazines |
|
| Diphenylalkylpiperazines |
|
| Pyrimidinylpiperazines | |
| Pyridinylpiperazines | |
| Benzo(iso)thiazolylpiperazines | |
| Tricyclic-linked piperazines |
|
| Others/uncategorized | |
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.
